We generated GGT1 knockdown cell lines using CRISPRi approaches and GGT1 KO cell lines (polyclonal and single-cell clones) using CRISPRCas9 approaches
Phase 2 trial data shows up to 24.2% body weight reduction at the 12mg dose over 48 weeks
Klow Peptide is formulated from four peptides selected for their complementarity: The rationale behind this formulation is based on a multi-target approach: each peptide acts on a distinct aspect of the repair and regeneration process, creating an overall synergistic effect
Genome Biol 3:112
Second, as glutathione in cells is mainly synthesized endogenously by its biochemical precursors, its parenteral administration may not result in a significant increase in the concentration of cellular glutathione levels (Hight et al., N-acetylcysteine (NAC), a cysteine precursor, is an antioxidant molecule that enhances the production of glutathione (Kopke et al., 2015)
A 2026 study comparing commercially administered NAD+ IV and nicotinamide-riboside IV offered preliminary short-term safety and tolerability information